Keywords: hospira, retacrit, maintains, hb, well, erypo, world
Hospira's Retacrit maintains Hb as well as Erypo
Article | 15 September 2008
World injectable generics giant Hospira's Retacrit (epoetin zeta) is as effective as Janssen-Cilag's Erypo (epoetin alfa) in achieving and maintaining ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
